Organogenesis Holding (ORGO) Tops Q4 EPS by 5c, provides guidance

Organogenesis Holding (NASDAQ: ORGO) reported Q4 EPS of $0.04, $0.05 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $126.66 million versus the consensus estimate of $109.61 million.

GUIDANCE:

Organogenesis Holding sees FY2025 revenue of $480-535 million, versus the consensus of $472.9 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• What Delta’s report tells investors in American and United
• Delta Air shares slip despite strong outlook, Melius says